Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+7.47%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$56.6B
AUM Growth
+$56.6B
(+4.9%)
Cap. Flow
+$402M
Cap. Flow
% of AUM
0.71%
Top 10 Holdings %
Top 10 Hldgs %
29.54%
Holding
970
New
110
Increased
281
Reduced
398
Closed
105
Top Buys
| 1 |
Broadcom
AVGO
|
$662M |
| 2 |
HES
Hess
HES
|
$285M |
| 3 |
3M
MMM
|
$208M |
| 4 |
Bristol-Myers Squibb
BMY
|
$187M |
| 5 |
Dover
DOV
|
$150M |
Top Sells
| 1 |
CSX Corp
CSX
|
$201M |
| 2 |
Merck
MRK
|
$191M |
| 3 |
Deere & Co
DE
|
$122M |
| 4 |
RB Global
RBA
|
$108M |
| 5 |
ConocoPhillips
COP
|
$106M |
Sector Composition
| 1 | Technology | 28.49% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 10.57% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Graphic Packaging
GPK
$6.6B
| – | – | -45,953 | Closed | -$1.2M |
|
902
HilleVax
HLVX
$105M
| – | – | -74,220 | Closed | -$1.07M |
|
903
Icon
ICLR
$13.8B
| – | – | -11,000 | Closed | -$3.45M |
|
904
Jack Henry & Associates
JKHY
$11.9B
| – | – | -61,886 | Closed | -$10.3M |
|
905
Kilroy Realty
KRC
$4.92B
| – | – | -320,898 | Closed | -$10M |
|
906
Keros Therapeutics
KROS
$618M
| – | – | -230,000 | Closed | -$10.5M |
|
907
Levi Strauss
LEVI
$8.85B
| – | – | -400,000 | Closed | -$7.71M |
|
908
Labcorp
LH
$23.1B
| – | – | -20,900 | Closed | -$4.25M |
|
909
Lennox International
LII
$19.6B
| – | – | -22,541 | Closed | -$12.1M |
|
910
LivaNova
LIVN
$3.08B
| – | – | -100,000 | Closed | -$5.48M |
|
911
Lincoln National
LNC
$8.14B
| – | – | -100,000 | Closed | -$3.11M |
|
912
Alliant Energy
LNT
$16.7B
| – | – | -45,908 | Closed | -$2.34M |
|
913
Leap Therapeutics
LPTX
$12M
| – | – | -113,743 | Closed | -$223K |
|
914
Mobileye
MBLY
$11.4B
| – | – | -300,000 | Closed | -$8.43M |
|
|
MFA
915
MFA Financial
MFA
$1.05B
| – | – | -225,000 | Closed | -$2.39M |
|
916
Maravai LifeSciences
MRVI
$350M
| – | – | -100,000 | Closed | -$716K |
|
917
Navigator Holdings
NVGS
$1.08B
| – | – | -125,000 | Closed | -$2.18M |
|
918
Omega Healthcare
OHI
$12.6B
| – | – | -325,000 | Closed | -$11.1M |
|
919
Ormat Technologies
ORA
$5.56B
| – | – | -50,000 | Closed | -$3.59M |
|
920
Blue Owl Capital
OWL
$12.1B
| – | – | -75,000 | Closed | -$1.33M |
|
921
Vaxcyte
PCVX
$4B
| – | – | -85,088 | Closed | -$6.42M |
|
922
Principal Financial Group
PFG
$17.9B
| – | – | -36,800 | Closed | -$2.89M |
|
923
Piper Sandler
PIPR
$5.9B
| – | – | -11,953 | Closed | -$2.75M |
|
924
Prudential Financial
PRU
$38.6B
| – | – | -189,351 | Closed | -$22.2M |
|
|
VRNA
925
Verona Pharma
VRNA
$9.16B
| – | – | -175,000 | Closed | -$2.53M |
|